Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.

"Declarations Conflict of interestMarta Campagnolo has received travel grants from Lusofarmaco. Roberta Biundo reports honoraria to speak from Bial. She is supported by the Ministry of Health under Grant No. GR-2016–02361986. Luca Weis reports no disclosures. Carmelo Fogliano reports no disclosures. Valeria Cianci reports no disclosures. Michela Garon reports no disclosures. Eleonora Fiorenzato reports no disclosures. Florinda Ferreri reports no disclosures. Patrizia Bisiacchi reports no disclosures. Miryam Carecchio reports no disclosures. Angelo Antonini has received compensation for consultancy and speaker related activities from UCB, Boehringer Ingelheim, Ever Pharma, General Electric, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Theravance Biopharma, Jazz Pharmaceuticals, Roche, Medscape; he receives research support from Bial, Lundbeck, Roche, Angelini Pharmaceuticals, Horizon 2020—Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation, and Movement Ingelheim for legal cases on pathological gambling. All authors declare that they have no conflict of interest in connection with this paper. Ethical approvalEthical approval was waived by the local Ethics Committee of University of Padova in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. Informed consentInformed consent was obtained from all individual participants included in the study. Conflict of interest Marta Campagnolo has received travel grants from Lusofarmaco. Roberta Biundo reports honoraria to speak from Bial. She is supported by the Ministry of Health under Grant No. GR-2016–02361986. Luca Weis reports no disclosures. Carmelo Fogliano reports no disclosures. Valeria Cianci reports no disclosures. Michela Garon reports no disclosures. Eleonora Fiorenzato reports no disclosures. Florinda Ferreri reports no disclosures. Patrizia Bisiacchi reports no disclosures. Miryam Carecchio reports no disclosures. Angelo Antonini has received compensation for consultancy and speaker related activities from UCB, Boehringer Ingelheim, Ever Pharma, General Electric, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Theravance Biopharma, Jazz Pharmaceuticals, Roche, Medscape; he receives research support from Bial, Lundbeck, Roche, Angelini Pharmaceuticals, Horizon 2020—Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation, and Movement Ingelheim for legal cases on pathological gambling. All authors declare that they have no conflict of interest in connection with this paper."

"Funding Open access funding provided by Università degli Studi di Padova within the CRUI-CARE Agreement. This work was supported by the Italian Ministry of Health under Grant No. GR-2016-02361986."